Hutchinson-Gilford Progeria Syndrome
Also known as: Progeria / Other specified endocrine disorders / Hutchinson-Gilford syndrome (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB06448 | Lonafarnib | A potent farnesyl transferase inhibitor used to reduce mortality associated with Hutchinson-Gilford progeria syndrome (HGPS) and other progeroid laminopathies. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB17634 | Progerinin | 1 | Completed | 1 |
DB01590 | Everolimus | 1 / 2 | Enrolling by Invitation | 1 |
DB06448 | Lonafarnib | 1 / 2 | Enrolling by Invitation | 1 |
DB00877 | Sirolimus | 1 / 2 | Completed | 1 |
DB06448 | Lonafarnib | 2 | Active Not Recruiting | 1 |
DB06448 | Lonafarnib | 2 | Completed | 2 |
DB00175 | Pravastatin | 2 | Active Not Recruiting | 1 |
DB00175 | Pravastatin | 2 | Completed | 2 |
DB00399 | Zoledronic acid | 2 | Active Not Recruiting | 1 |
DB00399 | Zoledronic acid | 2 | Completed | 2 |
DB06448 | Lonafarnib | Not Available | Approved for Marketing | 1 |